Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides

Clinical Chemistry

Volumn 51, Issue 4, 2005, Pages 708-718

  Ala Kopsala, Minna ^a   Ruskoaho, Heikki ^a   Leppäluoto, Juhani ^a   Seres, Leila ^b   Skoumal, Reka ^b   Toth, Miklos ^b,c,d   Horkay, Ferenc ^d   Vuolteenaho, Olli ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d Gottsegen Gyorgy Hung Inst C   (Hungary)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PROATRIAL NATRIURETIC PEPTIDE[29-98]; AMINO TERMINAL PROBRAIN NATRIURETIC PEPTIDE[1-37]; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS; VALVULAR HEART DISEASE;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY DISEASE; HEART VALVE DISEASES; HUMANS; IMMUNE SERA; IODINE RADIOISOTOPES; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; RECOMBINANT FUSION PROTEINS; REFERENCE VALUES;

EID: 16244380855     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.039891     Document Type: Article

References (24)

1. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-56.
2. Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994;235:561-76.
3. Clerico A, Del Ry S, Giannessi D. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in general practice: the need for a new generation of immunoassay method. Clin Chem 2000;46:1529-34.
4. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004;50:33-50.
5. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33.
6. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998;95:519-29.
7. Throughton R, Frampton C, Yandle T, Espiner E, Nicholls G, Richards M. Treatment of heart failure by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
8. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
9. Daly C, Fox K, Henein M. Natriuretic peptides in the diagnosis of heart disease - first amongst equals? Int J Cardiol 2002;84:107-13.
10. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-Terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002;106:2913-8.
11. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992;44:479-602.
12. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
13. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipälä J, Ruskoaho H, Leppäluoto J, et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004;50:1576-88.
14. Smith DBm Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
15. Seidler T, Pemberton C, Yandle T, Espiner E, Nicholls G, Richards M. The amino-terminal regions of proBNP and proANP oligomerize through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commum 1999;255:495-501.
16. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
17. Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger G, et al. N-Terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002;39:99-104.
18. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254-8.
19. Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med 2002;40:371-7.
20. Soos P, Juhasz-Nagy A, Ruskoaho H, Hartyanszky I, Merkely B, Toth M, et al. Locally different role atrial natriuretic peptide (ANP) in the pericardial fluid. Life Sci 2002;71:2563-73.
21. Ärnlöv J, Lind L, Stridsberg M, Andren B, Lithell H. N-Terminal atrial natriuretic peptide and left ventricular geometry and function in a population sample of elderly males. J Intern Med 2000;247:699-708.
22. Jesse RL. Neurohormonal regulation and the overlapping pathology between heart failure and coronary artery syndromes. Rev Cardiovasc Med 2003;4:S29-S36.
23. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
24. McCullough PA, Omland T, Maisel AS. B-Type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003;4:72-80.